Community pharmacy owners are having to take out bank loans, remortgage houses and dip into their own pockets to make up a ...

Stock analysts at Maxim Group started coverage on shares of Alterity Therapeutics (NASDAQ:ATHE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a ...

Alzheimer’s drugs should be prescribed like statins to stave off dementia, one of Britain’s leading neuroscientists has said.

Meta-Description: Drugmaker AbbVie could be set up for a big year in 2025 after completing another successful clinical trial ...

Risvodetinib is a small molecule commercialized by Inhibikase Therapeutics, with a leading Phase II program in Parkinson's Disease.

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

The NHS has paid out tens of thousands to a man who developed an “uncontrollable” gambling problem after he was given a common Parkinson’s drug, The Independent can reveal Philip Stevens, a 66 year ...

A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

The North Chicago-based drugmaker said it's received positive topline results in a Phase 3 trial of its investigational ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...